Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127772491 | 12777249 | 1 | I | 201604 | 20160913 | 20160924 | 20160924 | EXP | GB-MHRA-ADR 23637997 | GB-ACCORD-044171 | ACCORD | 84.00 | YR | M | Y | 0.00000 | 20160924 | PH | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127772491 | 12777249 | 1 | PS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | NIGHT | Y | 202446 | 10 | MG | QD | ||||||
127772491 | 12777249 | 2 | C | ALFUZOSIN | ALFUZOSIN | 1 | 0 | ||||||||||||
127772491 | 12777249 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
127772491 | 12777249 | 4 | C | BENDROFLUMETHIAZIDE | BENDROFLUMETHIAZIDE | 1 | 0 | ||||||||||||
127772491 | 12777249 | 5 | C | CLENIL MODULITE | BECLOMETHASONE DIPROPIONATE | 1 | 0 | ||||||||||||
127772491 | 12777249 | 6 | C | GARLIC EXTRACT | GARLIC | 1 | 0 | ||||||||||||
127772491 | 12777249 | 7 | C | LACTULOSE. | LACTULOSE | 1 | 0 | ||||||||||||
127772491 | 12777249 | 8 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
127772491 | 12777249 | 9 | C | MAGNESIUM HYDROXIDE. | MAGNESIUM HYDROXIDE | 1 | 0 | ||||||||||||
127772491 | 12777249 | 10 | C | MIRABEGRON | MIRABEGRON | 1 | 0 | ||||||||||||
127772491 | 12777249 | 11 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
127772491 | 12777249 | 12 | C | SALBUTAMOL | ALBUTEROL | 1 | 0 | ||||||||||||
127772491 | 12777249 | 13 | C | SERENOA REPENS | 2 | 0 | |||||||||||||
127772491 | 12777249 | 14 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
127772491 | 12777249 | 15 | C | ZINC OXIDE. | ZINC OXIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127772491 | 12777249 | 1 | Neuralgia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127772491 | 12777249 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127772491 | 12777249 | Aphasia | |
127772491 | 12777249 | Atrioventricular block complete | |
127772491 | 12777249 | Condition aggravated | |
127772491 | 12777249 | Muscular weakness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127772491 | 12777249 | 1 | 20160425 | 0 |